Evaluation of colistin-ampicillin/sulbactam combination efficacy in imipenem-resistant acinetobacter baumannii strains;İmipeneme Dirençli Acinetobacter baumannii İzolatlarinda Kolistin-Ampisilin/Sulbaktam Kombinasyonu Etkinliǧinin Deǧerlendirilmesi

Mikrobiyoloji Bulteni

Volumn 47, Issue 1, 2013, Pages 147-151

  Ikman, Aytekin Ç ^a   Ceylan, Mehmet Reşat ^b   Parlak, Mehmet ^c   Karahocagil, Mustafa Kasim ^b   BERKTAş, Mustafa ^b  

^a Mengucek Gazi Training and Research Hospital   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c Van Education and Research Hospital   (Turkey)

Author keywords

Acinetobacter baumannii; Ampicillin sulbactam; Colistin; Synergy

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; COLISTIN; IMIPENEM; SULBACTAM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; CROSS INFECTION; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMPICILLIN; ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; SULBACTAM;

EID: 84874380950     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannil: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 2011; 6( 4): 407-22.
2. Aşik G. Current approaches to explain the virulence of Acinetobacter baumannii. Mikrobiyol Bul 2011; 45( 2): 371-80.
3. Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010; 23( 4): 332-9.
4. Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, et al. Efficacy of rifampin and its combinations with imipenem, sulbactam, and Colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54( 3): 1165-72.
5. Giamarellos-Bourboulis EJ, Xirouchaki E, Giamarellou H. Interactions of Colistin and rifampin on multidrugresistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2001; 40(3): 117-20. (Pubitemid 32735549)
6. Akalin H. Çoklu ilaç direncinde tedavi yaklaşimi ve ilaç politikalari. ANKEM 2007; 21 ( Ek 2): 186-91.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16( 3): 128-40.
8. Horan TC, Andrus M, Dudek MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36(5): 309-32. (Pubitemid 351763841)
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement, M100-S20, 2010. CLSI, Wayne, PA.
10. Yildirim MI, Tuǧrul HM. Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains. Mikrobiyol Bul 2011; 45( 3): 422-9.
11. Yildiz O. Çoǧul dirençli Gram-negatiflerde tedavi yaklaşimi: Acinetobacter türleri. Yoǧun Bakim Derg 2007; 7( 1): 144-50.
12. Çiftci IH, Aşik G. Acinetobacter baumannii antibiyotik direnç mekanizmalan. ANKEM 2011; 25( 3): 196207.
13. Ozdem B, Gürelik FC, Celikbilek N, Balikçi H, Açikgöz ZC. Antibiotic resistance profiles of Acinetobacter species isolated from several clinical samples between 2007-2010. Mikrobiyol BuI 2011; 45( 3): 526-34.
14. Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V. In vitro activities of Colistin and ampicillin/sulbactam against Acinetobacter baumannii. J Med Assoc Thai 2011; 94( Suppl 3): S95-100.
15. Lee CH, Tang YF, Su LH, Chien CC, Liu JW. Antimicrobial effects of varied combinations of meropenem, sulbactam, and Colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microb Drug Resist 2008; 14( 3): 233-7.
16. Sung H, Choi SJ, Yoo S, Kim MN. In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii. Korean J Lab Med 2007; 27( 2): 111-7.
17. Rodriguez CH, De Ambrosio A, Bajuk M, et al. In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. J Infect Dev Ctries 2010; 4( 3): 164-7.
18. Principe L, D'Arezzo S, Capone A, Petrosillo N, Visca P. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob 2009; 8: 18.